Relationships between Neonatal Nutrition and Growth to 36 Weeks' Corrected Age in ELBW Babies-Secondary Cohort

Barbara E Cormack1,2, Yannan Jiang1, Jane E Harding1

  • 1Liggins Institute, University of Auckland, 1142 Auckland, New Zealand.

Nutrients
|March 19, 2020
PubMed

Insights

Optimizing nutrition, especially protein intake, in the first four weeks after birth is crucial for improving growth, particularly head growth, in extremely low birthweight (ELBW) infants up to 36 weeks corrected age.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Developmental Pediatrics

Background:

  • Extremely low birthweight (ELBW) infants face significant growth challenges.
  • Early nutrition is a key modifiable factor for neurodevelopment and growth in ELBW infants.

Purpose of the Study:

  • To investigate the relationship between nutrient intake in the first four weeks post-birth and growth outcomes up to 36 weeks corrected age in ELBW infants.
  • To identify specific nutrients associated with improved growth trajectories in this vulnerable population.

Main Methods:

  • Prospective cohort study of 434 ELBW infants within the ProVIDe randomized controlled trial.
  • Collection of macronutrient intake data from birth to 4 weeks.
  • Tracking of weight, length, and head circumference measurements from birth to 36 weeks corrected age.

Main Results:

  • Significant negative z-score changes observed for weight, length, and head circumference from birth to 36 weeks corrected age.
  • Protein intake during the first four weeks was correlated with changes in z-scores at 36 weeks corrected age.
  • Each 1 g·Kg -1 ·d -1 increase in protein intake during week 2 was associated with a 0.26 z-score increase in head circumference at 36 weeks corrected age.

Conclusions:

  • Early nutritional intake, particularly protein, is significantly associated with growth outcomes in ELBW infants.
  • Variability in nutritional practices and growth outcomes across different clinical sites suggests potential for improvement.
  • Enhanced nutritional strategies may be beneficial for optimizing growth in ELBW infants.

Related Concept Videos

Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
1.1K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
600
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
197
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
180
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
183